Aptiv
APTV
605 hedge funds and large institutions have $22.7B invested in Aptiv in 2019 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 223 increasing their positions, 201 reducing their positions, and 31 closing their positions.
226% more first-time investments, than exits
New positions opened: 101 | Existing positions closed: 31
11% more repeat investments, than reductions
Existing positions increased: 223 | Existing positions reduced: 201
11% more funds holding
Funds holding: 546 → 605 (+59)
6% more capital invested
Capital invested by funds: $21.4B → $22.7B (+$1.29B)
1.92% less ownership
Funds ownership: 95.54% → 93.63% (-1.9%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
57% less call options, than puts
Call options by funds: $39M | Put options by funds: $90M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$827M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$107M |
| 3 |
SIG
Senator Investment Group
New York
|
-$78.7M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$61.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.6M |
APTV Hedge Fund Activity: Q4 2019 in Review
605 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Aptiv (APTV) for Q4 2019, worth a combined $22.7B — up 6% from $21.4B a quarter earlier.
Buyers outnumbered sellers: 101 funds opened new APTV positions and 31 closed out — a net gain of 70 holders — while 223 added to existing stakes and 201 trimmed.
The largest buyer was American Century Companies, adding an estimated $289M. The largest seller was T. Rowe Price Associates, cutting an estimated $827M.
- 605 institutional investors held Aptiv (APTV) as of Q4 2019, up from 546 in Q3 2019.
- Funds reported $22.7B of Aptiv stock for Q4 2019, up 6% quarter-over-quarter.
- 101 funds opened new Aptiv positions in Q4 2019 and 31 closed out, a net change of +70 holders.
- The largest Aptiv buyer in Q4 2019 was American Century Companies, an estimated $289M added.
- The largest Aptiv seller in Q4 2019 was T. Rowe Price Associates, an estimated $827M sold.
Based on aggregated 13F filings for Q4 2019.